Vasoconstrictor Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: V868B6A82DD2EN
Market Monitor Global

Abstracts

Vasoconstrictor medicines belong to a class of drugs known as pressor drugs because they raise arterial pressure. These medications induce blood vessels to constrict by contracting the smooth muscle in the vessels. Because mean arterial pressure is determined by the product of systemic vascular resistance and cardiac output, constriction of arterial vessels raises systemic vascular resistance, which leads to a rise in arterial blood pressure. The Frank-Starling mechanism, which increases arterial pressure, increases venous blood pressure and increases cardiac preload and cardiac output when venous arteries are constricted.

This report contains market size and forecasts of Vasoconstrictor Drugs in Global, including the following market information:

Global Vasoconstrictor Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Vasoconstrictor Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vasoconstrictor Drugs include Pfizer, Fresenius Kabi, Par Pharmaceutical, Ferring B.V., Endo International, Astellas Pharma, Hybio Pharmaceutical, Cumberland Pharmaceuticals and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vasoconstrictor Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vasoconstrictor Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Vasoconstrictor Drugs Market Segment Percentages, by Type, 2021 (%)

• Tablet
• Injection
• Others

Global Vasoconstrictor Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Vasoconstrictor Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Vasoconstrictor Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Vasoconstrictor Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vasoconstrictor Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Vasoconstrictor Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Fresenius Kabi
• Par Pharmaceutical
• Ferring B.V.
• Endo International
• Astellas Pharma
• Hybio Pharmaceutical
• Cumberland Pharmaceuticals
• AstraZeneca
• Novartis
• Bayer
• Shanghai Soho-Yiming Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Vasoconstrictor Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Vasoconstrictor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VASOCONSTRICTOR DRUGS OVERALL MARKET SIZE

2.1 Global Vasoconstrictor Drugs Market Size: 2021 VS 2028
2.2 Global Vasoconstrictor Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Vasoconstrictor Drugs Players in Global Market
3.2 Top Global Vasoconstrictor Drugs Companies Ranked by Revenue
3.3 Global Vasoconstrictor Drugs Revenue by Companies
3.4 Top 3 and Top 5 Vasoconstrictor Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vasoconstrictor Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vasoconstrictor Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Vasoconstrictor Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Vasoconstrictor Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Vasoconstrictor Drugs Market Size Markets, 2021 & 2028
  4.1.2 Tablet
  4.1.3 Injection
  4.1.4 Others
4.2 By Type - Global Vasoconstrictor Drugs Revenue & Forecasts
  4.2.1 By Type - Global Vasoconstrictor Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Vasoconstrictor Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Vasoconstrictor Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Vasoconstrictor Drugs Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Vasoconstrictor Drugs Revenue & Forecasts
  5.2.1 By Application - Global Vasoconstrictor Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Vasoconstrictor Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Vasoconstrictor Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Vasoconstrictor Drugs Market Size, 2021 & 2028
6.2 By Region - Global Vasoconstrictor Drugs Revenue & Forecasts
  6.2.1 By Region - Global Vasoconstrictor Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Vasoconstrictor Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Vasoconstrictor Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Vasoconstrictor Drugs Revenue, 2017-2028
  6.3.2 US Vasoconstrictor Drugs Market Size, 2017-2028
  6.3.3 Canada Vasoconstrictor Drugs Market Size, 2017-2028
  6.3.4 Mexico Vasoconstrictor Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Vasoconstrictor Drugs Revenue, 2017-2028
  6.4.2 Germany Vasoconstrictor Drugs Market Size, 2017-2028
  6.4.3 France Vasoconstrictor Drugs Market Size, 2017-2028
  6.4.4 U.K. Vasoconstrictor Drugs Market Size, 2017-2028
  6.4.5 Italy Vasoconstrictor Drugs Market Size, 2017-2028
  6.4.6 Russia Vasoconstrictor Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Vasoconstrictor Drugs Market Size, 2017-2028
  6.4.8 Benelux Vasoconstrictor Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Vasoconstrictor Drugs Revenue, 2017-2028
  6.5.2 China Vasoconstrictor Drugs Market Size, 2017-2028
  6.5.3 Japan Vasoconstrictor Drugs Market Size, 2017-2028
  6.5.4 South Korea Vasoconstrictor Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Vasoconstrictor Drugs Market Size, 2017-2028
  6.5.6 India Vasoconstrictor Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Vasoconstrictor Drugs Revenue, 2017-2028
  6.6.2 Brazil Vasoconstrictor Drugs Market Size, 2017-2028
  6.6.3 Argentina Vasoconstrictor Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Vasoconstrictor Drugs Revenue, 2017-2028
  6.7.2 Turkey Vasoconstrictor Drugs Market Size, 2017-2028
  6.7.3 Israel Vasoconstrictor Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Vasoconstrictor Drugs Market Size, 2017-2028
  6.7.5 UAE Vasoconstrictor Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Vasoconstrictor Drugs Major Product Offerings
  7.1.4 Pfizer Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Fresenius Kabi
  7.2.1 Fresenius Kabi Corporate Summary
  7.2.2 Fresenius Kabi Business Overview
  7.2.3 Fresenius Kabi Vasoconstrictor Drugs Major Product Offerings
  7.2.4 Fresenius Kabi Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.2.5 Fresenius Kabi Key News
7.3 Par Pharmaceutical
  7.3.1 Par Pharmaceutical Corporate Summary
  7.3.2 Par Pharmaceutical Business Overview
  7.3.3 Par Pharmaceutical Vasoconstrictor Drugs Major Product Offerings
  7.3.4 Par Pharmaceutical Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.3.5 Par Pharmaceutical Key News
7.4 Ferring B.V.
  7.4.1 Ferring B.V. Corporate Summary
  7.4.2 Ferring B.V. Business Overview
  7.4.3 Ferring B.V. Vasoconstrictor Drugs Major Product Offerings
  7.4.4 Ferring B.V. Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.4.5 Ferring B.V. Key News
7.5 Endo International
  7.5.1 Endo International Corporate Summary
  7.5.2 Endo International Business Overview
  7.5.3 Endo International Vasoconstrictor Drugs Major Product Offerings
  7.5.4 Endo International Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.5.5 Endo International Key News
7.6 Astellas Pharma
  7.6.1 Astellas Pharma Corporate Summary
  7.6.2 Astellas Pharma Business Overview
  7.6.3 Astellas Pharma Vasoconstrictor Drugs Major Product Offerings
  7.6.4 Astellas Pharma Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.6.5 Astellas Pharma Key News
7.7 Hybio Pharmaceutical
  7.7.1 Hybio Pharmaceutical Corporate Summary
  7.7.2 Hybio Pharmaceutical Business Overview
  7.7.3 Hybio Pharmaceutical Vasoconstrictor Drugs Major Product Offerings
  7.7.4 Hybio Pharmaceutical Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.7.5 Hybio Pharmaceutical Key News
7.8 Cumberland Pharmaceuticals
  7.8.1 Cumberland Pharmaceuticals Corporate Summary
  7.8.2 Cumberland Pharmaceuticals Business Overview
  7.8.3 Cumberland Pharmaceuticals Vasoconstrictor Drugs Major Product Offerings
  7.8.4 Cumberland Pharmaceuticals Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.8.5 Cumberland Pharmaceuticals Key News
7.9 AstraZeneca
  7.9.1 AstraZeneca Corporate Summary
  7.9.2 AstraZeneca Business Overview
  7.9.3 AstraZeneca Vasoconstrictor Drugs Major Product Offerings
  7.9.4 AstraZeneca Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.9.5 AstraZeneca Key News
7.10 Novartis
  7.10.1 Novartis Corporate Summary
  7.10.2 Novartis Business Overview
  7.10.3 Novartis Vasoconstrictor Drugs Major Product Offerings
  7.10.4 Novartis Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.10.5 Novartis Key News
7.11 Bayer
  7.11.1 Bayer Corporate Summary
  7.11.2 Bayer Business Overview
  7.11.3 Bayer Vasoconstrictor Drugs Major Product Offerings
  7.11.4 Bayer Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.11.5 Bayer Key News
7.12 Shanghai Soho-Yiming Pharmaceuticals
  7.12.1 Shanghai Soho-Yiming Pharmaceuticals Corporate Summary
  7.12.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
  7.12.3 Shanghai Soho-Yiming Pharmaceuticals Vasoconstrictor Drugs Major Product Offerings
  7.12.4 Shanghai Soho-Yiming Pharmaceuticals Vasoconstrictor Drugs Revenue in Global Market (2017-2022)
  7.12.5 Shanghai Soho-Yiming Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Vasoconstrictor Drugs Market Opportunities & Trends in Global Market
Table 2. Vasoconstrictor Drugs Market Drivers in Global Market
Table 3. Vasoconstrictor Drugs Market Restraints in Global Market
Table 4. Key Players of Vasoconstrictor Drugs in Global Market
Table 5. Top Vasoconstrictor Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vasoconstrictor Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vasoconstrictor Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vasoconstrictor Drugs Product Type
Table 9. List of Global Tier 1 Vasoconstrictor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vasoconstrictor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Vasoconstrictor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vasoconstrictor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vasoconstrictor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Vasoconstrictor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vasoconstrictor Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vasoconstrictor Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Vasoconstrictor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vasoconstrictor Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vasoconstrictor Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vasoconstrictor Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vasoconstrictor Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vasoconstrictor Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vasoconstrictor Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vasoconstrictor Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Vasoconstrictor Drugs Product Offerings
Table 32. Pfizer Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Fresenius Kabi Corporate Summary
Table 34. Fresenius Kabi Vasoconstrictor Drugs Product Offerings
Table 35. Fresenius Kabi Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Par Pharmaceutical Corporate Summary
Table 37. Par Pharmaceutical Vasoconstrictor Drugs Product Offerings
Table 38. Par Pharmaceutical Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Ferring B.V. Corporate Summary
Table 40. Ferring B.V. Vasoconstrictor Drugs Product Offerings
Table 41. Ferring B.V. Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Endo International Corporate Summary
Table 43. Endo International Vasoconstrictor Drugs Product Offerings
Table 44. Endo International Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Astellas Pharma Corporate Summary
Table 46. Astellas Pharma Vasoconstrictor Drugs Product Offerings
Table 47. Astellas Pharma Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Hybio Pharmaceutical Corporate Summary
Table 49. Hybio Pharmaceutical Vasoconstrictor Drugs Product Offerings
Table 50. Hybio Pharmaceutical Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Cumberland Pharmaceuticals Corporate Summary
Table 52. Cumberland Pharmaceuticals Vasoconstrictor Drugs Product Offerings
Table 53. Cumberland Pharmaceuticals Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 54. AstraZeneca Corporate Summary
Table 55. AstraZeneca Vasoconstrictor Drugs Product Offerings
Table 56. AstraZeneca Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Novartis Corporate Summary
Table 58. Novartis Vasoconstrictor Drugs Product Offerings
Table 59. Novartis Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Bayer Corporate Summary
Table 61. Bayer Vasoconstrictor Drugs Product Offerings
Table 62. Bayer Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Shanghai Soho-Yiming Pharmaceuticals Corporate Summary
Table 64. Shanghai Soho-Yiming Pharmaceuticals Vasoconstrictor Drugs Product Offerings
Table 65. Shanghai Soho-Yiming Pharmaceuticals Vasoconstrictor Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Vasoconstrictor Drugs Segment by Type in 2021
Figure 2. Vasoconstrictor Drugs Segment by Application in 2021
Figure 3. Global Vasoconstrictor Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vasoconstrictor Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vasoconstrictor Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vasoconstrictor Drugs Revenue in 2021
Figure 8. By Type - Global Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 12. US Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 24. China Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vasoconstrictor Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vasoconstrictor Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Fresenius Kabi Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Par Pharmaceutical Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ferring B.V. Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Endo International Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Astellas Pharma Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hybio Pharmaceutical Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cumberland Pharmaceuticals Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AstraZeneca Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Novartis Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Shanghai Soho-Yiming Pharmaceuticals Vasoconstrictor Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)